Lavie Ofer, Ben-Arie Alon, Pilip Adalbert, Rennert Gad, Cohen Yoram, Feiner Beni, Auslnader Ron
Division of Gynecological Oncology, Carmel Medical Center, 7 Michal Street, Haifa 34362, Israel.
Gynecol Oncol. 2005 Nov;99(2):486-8. doi: 10.1016/j.ygyno.2005.06.009. Epub 2005 Jul 26.
Recently, a high incidence of BRCA1 cancer predisposing mutation was described among patients with Uterine Serous Papillary Carcinoma (USPC). A BRCA2 germline mutation in a USPC patient has never been reported.
A 65-year-old Ashkenazi Jewish woman was diagnosed with USPC Stage III A. The patient family history included a mother with ovarian carcinoma, a maternal aunt who had breast carcinoma that was diagnosed at an early age, an additional maternal aunt who suffered from gastric carcinoma, and the patient's sister who had duodenal carcinoma. The patient was found to be a carrier of the germline BRCA2 cancer predisposing mutation (6174delT).
We report the first case of a BRCA2 mutation in a USPC patient. A strong family history of breast and ovarian cancer with the presence of the BRCA2 germline mutation is an additional hint for the possible association between BRCA cancer predisposing mutations and USPC.
最近,子宫浆液性乳头状癌(USPC)患者中BRCA1癌症易感突变的发生率较高。USPC患者中从未报道过BRCA2种系突变。
一名65岁的德系犹太女性被诊断为III A期USPC。患者家族史包括患有卵巢癌的母亲、早年被诊断患有乳腺癌的一位姨妈、患有胃癌的另一位姨妈以及患有十二指肠癌的患者姐妹。该患者被发现是种系BRCA2癌症易感突变(6174delT)的携带者。
我们报告了首例USPC患者中BRCA2突变的病例。乳腺癌和卵巢癌家族史强烈且存在BRCA2种系突变,这进一步提示了BRCA癌症易感突变与USPC之间可能存在关联。